Featured Image
Photo by National Cancer Institute on Unsplash
Read the Original
This page is a summary of: Toward the development of an innovative pharmacological compound employing peptides for EGFR-mediated drug delivery in anaplastic thyroid carcinoma, Biochemical Pharmacology, January 2026, Elsevier,
DOI: 10.1016/j.bcp.2025.117448.
You can read the full text:
Contributors
The following have contributed to this page
